74 filings
8-K
VIR
Vir Biotechnology Inc
2 May 24
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:09pm
8-K
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
8-K
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
8-K
VIR
Vir Biotechnology Inc
20 Feb 24
Departure of Directors or Certain Officers
4:33pm
8-K
VIR
Vir Biotechnology Inc
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
8-K
yuh72o8bes0jd5r
3 Nov 23
Entry into a Material Definitive Agreement
4:37pm
8-K
t1t8wnem81lub1dzn9c
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
rjehkwn vj97q
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
8-K
kvmkc
20 Sep 23
Departure of Directors or Certain Officers
6:02am
8-K
cps174n9aml
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
srn4c wpt
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
j8sj95ifrdrvbnruo
23 May 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
am8c4css5gkpvm plt
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm
8-K
crirwvzf5w3fymssuq
10 Mar 23
Regulation FD Disclosure
9:45pm
8-K
xhud0nyr
8 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
l9sv9 wjkcgt7eqen
23 Feb 23
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm
8-K
9n1xfv
22 Feb 23
Other Events
8:41am
8-K
8ycp 3t7y
16 Feb 23
Departure of Directors or Certain Officers
8:36am
8-K
rfix6eg
13 Feb 23
Entry into a Material Definitive Agreement
4:31pm
8-K
2sgikff45s55 ex8asum
25 Jan 23
Departure of Directors or Certain Officers
8:33am